Seeing Is Believing
APLS is currently covered by 15 analysts with an average price target of $36.07. This is a potential upside of $9.6 (986.45%) from yesterday's end of day stock price of $3.32.
Apellis Pharmaceuticals's activity chart (see below) currently has 380 price targets and 311 ratings on display. The stock rating distribution of APLS is 38.89% HOLD and 61.11% BUY.
Analysts average stock forecasts to be materialized ratio is 67.65% with an average time for these price targets to be met of 205.92 days.
Highest price target for APLS is $52, Lowest price target is $18, average price target is $36.07.
Most recent stock forecast was given by from CANTOR FITZGERALD on 15-May-2026. First documented stock forecast 04-Dec-2017.
Currently out of the existing stock ratings of APLS, 14 are a HOLD (38.89%), 22 are a BUY (61.11%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-May-2026
$31
1 months 23 days ago
(15-May-2026)
4/22 (18.18%)
$13.11 (73.28%)
308
Buy Since 20-Jan-2026
$41
$37.23 (987.53%)
$26
2 months 21 days ago
(17-Apr-2026)
15/18 (83.33%)
$0.1 (0.24%)
100
Hold Since 02-Nov-2023
$41
$37.23 (987.53%)
$20
3 months 6 days ago
(02-Apr-2026)
14/19 (73.68%)
$0.59 (1.46%)
147
Buy Since 19-Jul-2022
$41
$37.23 (987.53%)
$48
3 months 7 days ago
(01-Apr-2026)
4/29 (13.79%)
$0.61 (1.51%)
90
Buy Since 19-Jan-2024
$41
$37.23 (987.53%)
$45
3 months 7 days ago
(01-Apr-2026)
16/28 (57.14%)
$0.61 (1.51%)
368
What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?